Dalia Dassa Kaye is the director of the Center for Middle East Public Policy at RAND Corporation.
Dalia Dassa Kaye on KCRW
More from KCRW
Why are public health experts wary of RFK Jr. as HHS head?
PoliticsWhat can we expect if RFK Jr. becomes health secretary? Will Trump take action on Dreamers? Plus, KCRW analyzes how progressives influenced the Democratic mandate.
Have hurricanes gotten swept up in the culture wars?
PoliticsThe recent hurricanes unleashed a storm of conspiracies. Could Omaha voters decide the nation’s fate? Plus, an indie newsletter saved a politically divided marriage.
Michael Tracey: Why working class Americans of all races voted for Trump
PoliticsReporting on the election often involves being glued to computer screens dictating the polling numbers around the country and using statistics revolving around race and gender to make…
Trump and Harris try distancing themselves from campaign mistakes
PoliticsKCRW provides an election outlook with a week to go. Can the electorate stop being driven by hate? Plus, what was the Washington Post’s real mistake?
Donald Trump to lose Orange County for third time
Election 2024While election day is over, votes are still being counted in Orange County. Currently Vice-President Kamala Harris is leading Donald Trump in Orange County.
Was civility the winner of the VP debate?
PoliticsCan civility influence voters in the Trump era? Has Biden’s policy in the Middle East backfired? Plus, the United States hits a bleak milestone on executions.
Election results in Orange County could reshape Congress
Orange CountyThe outcome of congressional races in Orange County could determine whether Republicans keep their majority in the House of Representatives.
Voters feel less polarized post-Trump win, unlike divided Democratic Party
PoliticsNew polling shows Americans feel less divided post-election. Can Donald Trump “end all wars” this term? Plus, KCRW analyzes the future of the progressive agenda.
Assassinating the Myths of Healthcare
Health & WellnessMuch needed attention has been brought upon the for-profit health insurance industry in the wake of the assassination of UnitedHealthcare CEO Brian Thompson.